This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Feb;57(2):356-7.

doi: 10.1016/j.eururo.2009.11.019.

Words of wisdom. Re: anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

Philippe Beuzeboc¹

Affiliations

PMID: 20116769
DOI: 10.1016/j.eururo.2009.11.019

Comment

Words of wisdom. Re: anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

Philippe Beuzeboc. Eur Urol. 2010 Feb.

. 2010 Feb;57(2):356-7.

doi: 10.1016/j.eururo.2009.11.019.

Author

Philippe Beuzeboc¹

Affiliation

¹ Institut Curie, 26 rue d'Ulm, Paris 75005 France. philippe.beuzeboc@curie.net

PMID: 20116769
DOI: 10.1016/j.eururo.2009.11.019

No abstract available

PubMed Disclaimer

Comment on

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.
Chen Y, Clegg NJ, Scher HI. Chen Y, et al. Lancet Oncol. 2009 Oct;10(10):981-91. doi: 10.1016/S1470-2045(09)70229-3. Lancet Oncol. 2009. PMID: 19796750 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science